In this regard, the poultry vaccines market is expected to project phenomenal growth, growing from US$2.1 billion in the year 2023 to US$4.1 billion in 2031 at a CAGR of 8.6% during the forecast period. This increase in the market size will be due to an increase in the incidence of diseases in poultry and also due to significant developments currently taking place in vaccine technology.
This market would, therefore, be driven a great deal by the incidences of poultry diseases, which, through their economic impacts, pose great threats. Poultry plays an important role in animal protein production through meat and eggs, and many zoonotic diseases threaten the whole industry—a reduction in poultry rearing and significant economic losses, particularly in developing nations. For example, poultry coccidiosis remains one of the common diseases that result in massive losses through mortality, reduction in body weight, and costs associated with prophylactic measures and therapies. The upsurge in the threat presented by such diseases has, in turn, hiked demands for their efficient vaccines, driving the market.
The market is segmented into broiler and layer vaccines. As of 2023, the broiler segment constitutes the largest share of the market. Broilers are small chickens grown for their meat. The fast growth and intensive breeding make these chicken segments highly susceptible to diseases. Vaccination plays an important role in averting outbreaks and maintaining healthy birds. For example, broiler chicks are immunized in the hatchery itself against Marek’s disease, which can be quite disastrous. The significance of the broiler industry shows that the vaccines are highly instrumental in maintaining the broiler flocks of chickens as healthy and productive.
Regional Outlook: Africa- An Emerging Market
The only region, other than the Asia Pacific that will continue to be a significant contributor to the poultry vaccines market is Africa. The African poultry sector has been growing owing to an increase in demand for poultry meat and eggs due to its population and urbanization boom. This growth has come with increased consciousness of animal health and the need for disease management, pushing up the demand for vaccines even more.
Many serious troubles beset the poultry industry, not least being the frequent outbreaks of some very serious diseases. They are unfortunate as poor vaccination cover has been a feature of the Newcastle diseases and avian influenzas that have so often plagued the region, leading to serious economic losses and food insecurity. The aim would thus increasingly be toward the improvement of the vaccination programs and enlargement of vaccination access throughout the continent.
Various African countries are building up infrastructure dealing with poultry health, and there are attempts by governments and organizations to make vaccines more accessible and effective. Since then, cold chain logistics have improved on various counts-a very important factor in sustaining the efficacy of vaccines in rural and remote areas. This, coupled with growing investment in local vaccine production and distribution, is an attempt to cut dependency on imports and make them more affordable.
Besides, the development of poultry keeping in Africa opens more perspectives for market expansion. That is, advanced vaccines and enhanced practices of disease management will be in higher demand as the poultry industry across the continent is expanding. Innovation in such forms as vectored and combination vaccines, promising better protection and higher efficacy, are likely to play a leading role in overcoming such challenges before the African poultry sector.
These factors, therefore, remain amply strong in making the statement that the poultry vaccines market has been projected for strong growth with the growing prevalence of poultry diseases and improvement in vaccine technology. The dominant role of the Asia Pacific is challenged by Africa, in view of the latter’s growing poultry industry and increasing awareness over improving the management of diseases. This trend is expected to continue in years to come, driven by innovation in vaccine development on the back of increasing regionalization; this will provide a driver for global poultry health and sustainability of growth from both established and developing markets.
